Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase II Pilot Study of Expanded Natural Killer Cells and Elotuzumab to Eradicate High-Risk Myeloma Post Autologous Stem Cell Transplant


Collapse Overview 
Collapse sponsor award id
CA204


Collapse Biography 

Collapse Time 
Collapse start date
2017-03-16

Collapse end date
2020-03-16